Literature DB >> 28258664

Surgical and not analgesic technique affects postoperative inflammation following colorectal cancer surgery: a prospective, randomized study.

W Siekmann1, C Eintrei2, A Magnuson3, A Sjölander4, P Matthiessen5, P Myrelid6,7, A Gupta8.   

Abstract

AIM: Epidural analgesia reduces the surgical stress response. However, its effect on pro- and anti-inflammatory cytokines in the genesis of inflammation following major abdominal surgery remains unclear. Our main objective was to elucidate whether perioperative epidural analgesia prevents the inflammatory response following colorectal cancer surgery.
METHODS: Ninety-six patients scheduled for open or laparoscopic surgery were randomized to epidural analgesia (group E) or patient-controlled intravenous analgesia (group P). Surgery and anaesthesia were standardized in both groups. Plasma cortisol, insulin and serum cytokines [interleukin 1β (IL-1β), IL-4, IL-5, IL-6, IL-8, IL-10, IL-12p70, IL-13, tumour necrosis factor α, interferon γ, granulocyte-macrophage colony-stimulating factor, prostaglandin E2 and vascular endothelial growth factor] were measured preoperatively (T0), 1-6 h postoperatively (T1) and 3-5 days postoperatively (T2). Mixed model analysis was used, after logarithmic transformation when appropriate, for analyses of cytokines and stress markers.
RESULTS: >There were no significant differences in any serum cytokine concentration between groups P and E at any time point except for IL-10 which was 87% higher in group P [median and range 4.1 (2.3-9.2) pg/ml] compared to group E [2.6 (1.3-4.7) pg/ml] (P = 0.002) at T1. There was no difference in plasma cortisol and insulin between the groups at any time point after surgery. A significant difference in median serum cytokine concentration was found between open and laparoscopic surgery with higher levels of IL-6, IL-8 and IL-10 at T1 in patients undergoing open surgery compared to laparoscopic surgery. No difference in serum cytokine concentration was detected between the groups or between the surgical technique at T2.
CONCLUSIONS: Open surgery, compared to laparoscopic surgery, has greater impact on these inflammatory mediators than epidural analgesia vs intravenous analgesia. Colorectal Disease
© 2017 The Association of Coloproctology of Great Britain and Ireland.

Entities:  

Keywords:  Anaesthesia; colorectal cancer; cytokines; epidural; inflammation; surgery

Mesh:

Substances:

Year:  2017        PMID: 28258664     DOI: 10.1111/codi.13643

Source DB:  PubMed          Journal:  Colorectal Dis        ISSN: 1462-8910            Impact factor:   3.788


  19 in total

1.  Effect of Enhanced Recovery after Surgery with Integrated Traditional Chinese and Western Medicine on Postoperative Stress Response of Patients with Gastrointestinal Tumors.

Authors:  Haiping Zhao; Wenhui Sun
Journal:  Comput Math Methods Med       Date:  2022-07-08       Impact factor: 2.809

2.  Comparing the Effects of Combined General/Epidural Anaesthesia and General Anaesthesia on Serum Cytokine Levels in Radical Cystectomy.

Authors:  Meltem Savran Karadeniz; Orkhan Mammadov; Hayriye Şentürk Çiftci; Sebahat Akgül Usta; Kamil Pembeci
Journal:  Turk J Anaesthesiol Reanim       Date:  2017-08-01

3.  Epidural analgesia versus patient-controlled intravenous analgesia for pain following intra-abdominal surgery in adults.

Authors:  Jon H Salicath; Emily Cy Yeoh; Michael H Bennett
Journal:  Cochrane Database Syst Rev       Date:  2018-08-30

4.  Surgical stress and metabolic response after totally laparoscopic right colectomy.

Authors:  Marco Milone; Antonella Desiderio; Nunzio Velotti; Michele Manigrasso; Sara Vertaldi; Umberto Bracale; Michele D'Ambra; Giuseppe Servillo; Giuseppe De Simone; Fatima Domenica Elisa De Palma; Giuseppe Perruolo; Gregory Alexander Raciti; Claudia Miele; Francesco Beguinot; Giovanni Domenico De Palma
Journal:  Sci Rep       Date:  2021-05-06       Impact factor: 4.379

5.  Does local infiltration analgesia reduce peri-operative inflammation following total hip arthroplasty? A randomized, double-blind study.

Authors:  J Kuchálik; A Magnuson; E Tina; A Gupta
Journal:  BMC Anesthesiol       Date:  2017-05-03       Impact factor: 2.217

6.  C-Reactive Protein to Albumin Ratio Predicts 30-Day and 1-Year Mortality in Postoperative Patients after Admission to the Intensive Care Unit.

Authors:  Tak Kyu Oh; Eunjeong Ji; Hyo-Seok Na; Byunghun Min; Young-Tae Jeon; Sang-Hwan Do; In-Ae Song; Hee-Pyoung Park; Jung-Won Hwang
Journal:  J Clin Med       Date:  2018-02-26       Impact factor: 4.241

7.  High Visceral to Subcutaneous Fat Ratio Is Associated with Increased Postoperative Inflammatory Response after Colorectal Resection in Inflammatory Bowel Disease.

Authors:  Yao Wei; Feng Zhu; Jianfeng Gong; Jianbo Yang; Tenghui Zhang; Lili Gu; Weiming Zhu; Zhen Guo; Yi Li; Ning Li; Jieshou Li
Journal:  Gastroenterol Res Pract       Date:  2018-04-03       Impact factor: 2.260

Review 8.  Surgical trauma-induced immunosuppression in cancer: Recent advances and the potential therapies.

Authors:  Fan Tang; Yan Tie; Chongqi Tu; Xiawei Wei
Journal:  Clin Transl Med       Date:  2020-01

Review 9.  Surgical stress response and promotion of metastasis in colorectal cancer: a complex and heterogeneous process.

Authors:  Corina Behrenbruch; Carolyn Shembrey; Sophie Paquet-Fifield; Christina Mølck; Hyun-Jung Cho; Michael Michael; Benjamin N J Thomson; Alexander G Heriot; Frédéric Hollande
Journal:  Clin Exp Metastasis       Date:  2018-01-15       Impact factor: 4.510

Review 10.  Interferon-γ and Colorectal Cancer: an up-to date.

Authors:  Christoforos Kosmidis; Konstantinos Sapalidis; Triantafyllia Koletsa; Maria Kosmidou; Christoforos Efthimiadis; George Anthimidis; Nikolaos Varsamis; Nikolaos Michalopoulos; Charilaos Koulouris; Stefanos Atmatzidis; Lazaros Liavas; Titika-Marina Strati; Georgios Koimtzis; Alexandros Tsakalidis; Stylianos Mantalovas; Katerina Zarampouka; Maria Florou; Dimitrios E Giannakidis; Eleni Georgakoudi; Sofia Baka; Paul Zarogoulidis; Yan-Gao Man; Isaac Kesisoglou
Journal:  J Cancer       Date:  2018-01-01       Impact factor: 4.207

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.